Literature DB >> 14668335

Observation and characterization of the interaction between a single immunoglobulin binding domain of protein L and two equivalents of human kappa light chains.

Nicholas G Housden1, Steven Harrison, Hazel R Housden, Karen-Anne Thomas, Jennifer A Beckingham, Siân E Roberts, Stephen P Bottomley, Marc Graille, Enrico Stura, Michael G Gore.   

Abstract

Detailed stopped-flow studies in combination with site-directed mutagenesis, isothermal titration calorimetry data and x-ray crystallographic knowledge have revealed that the biphasic pre-equilibrium fluorescence changes reported for a single Ig-binding domain of protein L from Peptostreptococcus magnus binding to kappa light chain are due to the binding of the kappa light chain at two separate sites on the protein L molecule. Elimination of binding site 2 through the mutation A66W has allowed the K(d) for kappa light chain binding at site 1 to be measured by stopped-flow fluorescence and isothermal titration calorimetry techniques, giving values of 48.0 +/- 8.0 nM and 37.5 +/- 7.3 nM respectively. Conversely, a double mutation Y53F/L57H eliminates binding at site 1 and has allowed the K(d) for binding at site 2 to be determined. Stopped-flow fluorimetry suggests this to be 3.4 +/- 0.8 microM in good agreement with the value of 4.6 +/- 0.8 microM determined by isothermal titration calorimetry. The mutation Y53F reduces the affinity of site 1 to approximately that of site 2.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14668335     DOI: 10.1074/jbc.M312938200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

1.  Evolutionary redefinition of immunoglobulin light chain isotypes in tetrapods using molecular markers.

Authors:  Sabyasachi Das; Nikolas Nikolaidis; Jan Klein; Masatoshi Nei
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-21       Impact factor: 11.205

2.  Antigen-specific, antibody-coated, exosome-like nanovesicles deliver suppressor T-cell microRNA-150 to effector T cells to inhibit contact sensitivity.

Authors:  Krzysztof Bryniarski; Wlodzimierz Ptak; Asha Jayakumar; Kerstin Püllmann; Michael J Caplan; Arthit Chairoungdua; Jun Lu; Brian D Adams; Emilia Sikora; Katarzyna Nazimek; Susanna Marquez; Steven H Kleinstein; Panjamaporn Sangwung; Yasuko Iwakiri; Eric Delgato; Frank Redegeld; Bart R Blokhuis; Jacek Wojcikowski; Anna Wladyslawa Daniel; Tom Groot Kormelink; Philip W Askenase
Journal:  J Allergy Clin Immunol       Date:  2013-05-31       Impact factor: 10.793

3.  Development of a high affinity, non-covalent biologic to add functionality to Fabs.

Authors:  Kendra N Avery; Cindy Zer; Krzysztof P Bzymek; John C Williams
Journal:  Sci Rep       Date:  2015-01-15       Impact factor: 4.379

4.  A method to confer Protein L binding ability to any antibody fragment.

Authors:  Zineb Lakhrif; Martine Pugnière; Corinne Henriquet; Anne di Tommaso; Isabelle Dimier-Poisson; Philippe Billiald; Matthieu O Juste; Nicolas Aubrey
Journal:  MAbs       Date:  2015-12-18       Impact factor: 5.857

Review 5.  Superantigen Recognition and Interactions: Functions, Mechanisms and Applications.

Authors:  Anthony M Deacy; Samuel Ken-En Gan; Jeremy P Derrick
Journal:  Front Immunol       Date:  2021-09-20       Impact factor: 7.561

6.  Antibody light chain variable domains and their biophysically improved versions for human immunotherapy.

Authors:  Dae Young Kim; Rebecca To; Hiba Kandalaft; Wen Ding; Henk van Faassen; Yan Luo; Joseph D Schrag; Nadereh St-Amant; Mary Hefford; Tomoko Hirama; John F Kelly; Roger MacKenzie; Jamshid Tanha
Journal:  MAbs       Date:  2014 Jan-Feb       Impact factor: 5.857

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.